Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
28717140
TITLE
Common variants of T-cells contribute differently to phenotypic variation in sarcoidosis.
ABSTRACT
The involvement of the immune system, particularly the role of T-cells, in sarcoidosis is unclear. The existence of higher CD4+ T-cells and increased CD4/CD8 ratio may indicate a pathogenic role of T-cells in the disease. In this study, we quantified the contribution of T-cells associated variants and of CD4/CD8 ratio in sarcoidosis phenotypes, Löfgren's syndrome (LS) and non- Löfgren's syndrome (non-LS). We employed a polygenic-based approach using genome-wide association studies results on relative levels of T-cells in healthy individuals to measure the genetic contribution of T-cells in sarcoidosis entities. Results revealed that the genetic architecture of LS is highly influenced by genetic variants associated with CD8+ T-cells and CD4/CD8 ratio, explaining up to 7.94% and 6.49% of LS variation, respectively; whereas, the genetic architecture of non-LS is minimally influenced by T-cells, explaining a phenotypic variation of <1%. Moreover, pleiotropy assessment between T-cells and LS/non-LS associated-variants led to the discovery of highly scored pathway maps that shared common factors related to antigen presentation and T-cell regulatory mechanisms. Differences in significant polygenic scores, presence of pleiotropy, and distinct genetic factors provide further insights on how genetic variants and genes associated with relative levels of T-cell subtypes contribute differently to sarcoidosis phenotypes.
DATE PUBLISHED
2017 Jul 17
HISTORY
PUBSTATUS PUBSTATUSDATE
received 2016/09/28
accepted 2017/06/02
entrez 2017/07/19 06:00
pubmed 2017/07/19 06:00
medline 2017/07/19 06:00
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Rivera NV Rivera Natalia V NV Center for Molecular Medicine, Karolinska Institutet, SE-171 76, Stockholm, Sweden. natalia.rivera@ki.se.
Hagemann-Jensen M Hagemann-Jensen Michael M Center for Molecular Medicine, Karolinska Institutet, SE-171 76, Stockholm, Sweden.
Ferreira MAR Ferreira Manuel A R MAR QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Queensland, 4029, Australia.
Kullberg S Kullberg Susanna S Department of Medicine, Respiratory Unit, Karolinska Institutet, Karolinska University Hospital, SE-171 76, Stockholm, Sweden.
Eklund A Eklund Anders A Department of Medicine, Respiratory Unit, Karolinska Institutet, Karolinska University Hospital, SE-171 76, Stockholm, Sweden.
Martin NG Martin Nicholas G NG QIMR Berghofer Medical Research Institute, Royal Brisbane Hospital, Queensland, 4029, Australia.
Padyukov L Padyukov Leonid L Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, SE-171 76, Stockholm, Sweden.
Grunewald J Grunewald Johan J Center for Molecular Medicine, Karolinska Institutet, SE-171 76, Stockholm, Sweden. johan.grunewad@ki.se.
INVESTIGATORS
JOURNAL
VOLUME: 7
ISSUE: 1
TITLE: Scientific reports
ISOABBREVIATION: Sci Rep
YEAR: 2017
MONTH: Jul
DAY: 17
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN: 2045-2322
ISSNTYPE: Electronic
MEDLINE JOURNAL
MEDLINETA: Sci Rep
COUNTRY: England
ISSNLINKING: 2045-2322
NLMUNIQUEID: 101563288
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
COMMENTS AND CORRECTIONS
REFTYPE REFSOURCE REFPMID NOTE
Cites Immunity. 2009 Jan 16;30(1):155-67 19144320
Cites Nat Genet. 2013 Oct;45(10):1150-9 23974872
Cites J Clin Invest. 2007 Nov;117(11):3576-82 17975675
Cites Cell. 2007 Feb 23;128(4):635-8 17320500
Cites Nat Genet. 2010 Jul;42(7):565-9 20562875
Cites PLoS One. 2012;7(8):e43907 22952805
Cites Genes Immun. 2000 Oct;1(7):423-7 11196672
Cites Trends Genet. 2013 Feb;29(2):66-73 23140989
Cites Nat Genet. 2011 Jun;43(6):519-25 21552263
Cites Chest. 1993 Aug;104(2):352-61 8339618
Cites PLoS Genet. 2013 Mar;9(3):e1003348 23555274
Cites Am J Respir Crit Care Med. 2016 May 1;193(9):1008-22 26651848
Cites Hum Mol Genet. 2009 Sep 15;18(18):3525-31 19553258
Cites Am J Respir Crit Care Med. 2001 Sep 1;164(5):840-6 11549543
Cites Nat Rev Genet. 2004 Dec;5(12):889-99 15573121
Cites Nat Genet. 2008 Sep;40(9):1103-6 19165924
Cites Twin Res. 1999 Dec;2(4):250-7 10723803
Cites Am J Respir Crit Care Med. 1999 Aug;160(2):736-55 10430755
Cites Am J Hum Genet. 2010 Jan;86(1):88-92 20045101
Cites Am J Respir Crit Care Med. 2015 Sep 15;192(6):727-36 26051272
Cites PLoS Biol. 2011 Jan 18;9(1):e1000579 21267061
Cites Genes Immun. 2011 Mar;12(2):67-77 21179114
Cites Nat Immunol. 2007 Jul;8(7):732-42 17546033
Cites Curr Opin Immunol. 2009 Jun;21(3):274-80 19524429
Cites Immunogenetics. 2008 Jan;60(1):1-18 18193213
Cites Genes Immun. 2005 Sep;6(6):509-18 15951742
Cites Genet Epidemiol. 2010 Dec;34(8):816-34 21058334
Cites Annu Rev Immunol. 2006;24:607-56 16551261
Cites PLoS One. 2012;7(8):e43644 22952729
Cites Genetics. 2010 Nov;186(3):767-73 21062962
Cites Eur Respir J. 2013 Apr;41(4):888-900 22936702
Cites Nature. 2009 Aug 6;460(7256):748-52 19571811
Cites Immunity. 2006 Nov;25(5):717-29 17070076
GRANTS
GENERAL NOTE
KEYWORDS
MESH HEADINGS
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
OTHER ID's